Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,707,429
  • Shares Outstanding, K 19,897
  • Annual Sales, $ 0 K
  • Annual Income, $ -373,630 K
  • 60-Month Beta -0.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.95
Trade MDGL with:

Options Overview Details

View History
  • Implied Volatility 59.19% ( +1.08%)
  • Historical Volatility 64.58%
  • IV Percentile 14%
  • IV Rank 10.54%
  • IV High 156.35% on 02/23/24
  • IV Low 47.74% on 03/28/24
  • Put/Call Vol Ratio 0.31
  • Today's Volume 419
  • Volume Avg (30-Day) 2,041
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 40,924
  • Open Int (30-Day) 41,535

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -6.06
  • Number of Estimates 7
  • High Estimate -4.86
  • Low Estimate -6.81
  • Prior Year -4.23
  • Growth Rate Est. (year over year) -43.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
236.49 +0.04%
on 04/12/24
299.98 -21.13%
on 03/15/24
-26.08 (-9.93%)
since 03/12/24
3-Month
168.25 +40.62%
on 02/09/24
299.98 -21.13%
on 03/15/24
+0.79 (+0.34%)
since 01/12/24
52-Week
119.76 +97.55%
on 10/27/23
322.67 -26.68%
on 05/01/23
-4.94 (-2.05%)
since 04/12/23

Most Recent Stories

More News
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 236.59 (-3.54%)
AXSM : 69.15 (-3.60%)
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

These businesses should see good times ahead.

MDGL : 236.59 (-3.54%)
VKTX : 68.62 (-3.17%)
1 No-Brainer Growth Stock to Buy Now

This liver-disease specialist might be significantly undervalued.

MDGL : 236.59 (-3.54%)
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

Both stocks are pretty risky, but one of them more so than the other.

VKTX : 68.62 (-3.17%)
MDGL : 236.59 (-3.54%)
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?

MDGL : 236.59 (-3.54%)
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock

This biotech just got clearance to dive into a deep ocean of a market.

MDGL : 236.59 (-3.54%)
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?

The mid-cap biotech has succeeded where many others failed.

MDGL : 236.59 (-3.54%)
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?

Madrigal has one key advantage over its two huge potential future rivals.

LLY : 751.64 (-1.05%)
NVO : 124.51 (-0.71%)
MDGL : 236.59 (-3.54%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 3.97 (-5.48%)
GLMD : 0.4190 (-0.12%)
VKTX : 68.62 (-3.17%)
ETNB : 9.82 (-3.16%)
IVA : 3.55 (-4.05%)
SGMT : 4.83 (-7.47%)
TERN : 5.14 (-1.53%)
NVO : 124.51 (-0.71%)
IQV : 234.23 (-1.59%)
MDGL : 236.59 (-3.54%)
Stocks Settle Lower as Bond Yields Climb on Inflation Concerns

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.15%. Stocks on Friday...

$SPX : 5,123.41 (-1.46%)
SPY : 510.85 (-1.38%)
$DOWI : 37,983.24 (-1.24%)
DIA : 379.87 (-1.21%)
$IUXX : 18,003.49 (-1.66%)
QQQ : 438.27 (-1.59%)
ZNM24 : 108-220s (+0.53%)
JBL : 134.07 (-2.86%)
ADBE : 474.09 (-2.10%)
ULTA : 442.32 (-1.25%)
AMZN : 186.13 (-1.54%)
MSFT : 421.90 (-1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 251.33
2nd Resistance Point 248.34
1st Resistance Point 242.47
Last Price 236.59
1st Support Level 233.60
2nd Support Level 230.61
3rd Support Level 224.74

See More

52-Week High 322.67
Fibonacci 61.8% 245.16
Last Price 236.59
Fibonacci 50% 221.22
Fibonacci 38.2% 197.27
52-Week Low 119.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar